Paraquat resistance gene and a vascular tissue- and trichome-specific promotor

BACKGROUND OF THE INVENTION

Field of the Invention

0001The present invention relates to a paraquat resistance gene imparting paraquat resistance and a vascular tissue - and trichome-specific promoter.

Background Art

0002Plants are exposed to various environmental stresses on a regular basis including high and low temperatures, drought, high light intensity, salinity, air pollutant gases, pathogenic microbes and the like. Therefore, if useful plants that can grow sufficiently even under such types of environmental stresses such as, for example, crops, can be developed, food production will become possible even in regions in which crops and the like can not currently grow due to environmental stresses, and the possibility of being prepared for a grave food crisis that is forecast in the future will be increased. Consequently, the production of plants that have improved resistance to such kinds of environmental stresses is underway on a global basis. For example, plants have been produced that were imparted with chilling resistance (Nature, 356, 710-703, 1992; Plant Physiol., 105, 601-605, 1994), drought resistance (Plant Physiol., 107, 125-130, 1995; Nature, 379, 683-684, 1996; Nature Biotech., 17, 287-291, 1999), salt resistance (Science, 259, 508-510, 1993; Biotechnology, 14, 177-180, 1996; Plant J., 12, 133-142, 1997), air pollutants resistance (Plant Cell Physiol., 34, 129-135, 1993; Biotechnology, 12, 165-168, 1994), disease resistance (Kagaku to Seibutsu (Chemistry and Organisms), 37, 295-305, 385-392, 1999) and the like by genetic recombination techniques. Further, some plants that have been imparted with resistance to agricultural chemicals by genetic recombination techniques are in practical use (Nature, 317, 741-744, 1985; Proc. Natl. Acad. Sci. USA, 85, 391-395, 1988; EMBO J., 6, 2513-2518, 1987; EMBO J., 7, 1241-1248, 1988).

0003These environmental stresses are closely related with <i>in vivo</i> generation of active oxygen species (superoxide radical (O₂^-), hydrogen peroxide (H₂O₂), hydroxy radical (OH^-)). Active oxygen species are generated by respiration, photosynthesis, environmental stresses and the like, and impart fatal damage to cells by excessive oxidation of proteins, nucleic acids, membrane structure or the like. It has also been reported that an active oxygen-resistant plant produced by genetic recombination techniques showed improved resistance to the aforementioned environmental stresses (Plant Physiol., 111, 1177-1181, 1996; FEBS Letters, 428,47-51, 1998).

0004To produce an active oxygen-resistant plant, a method is principally employed in which a gene of enzyme scavenging active oxygen species (superoxide dismutase, ascorbate peroxidase, catalase and glutathione reductase and the like) is introduced into the plant.

0005Paraquat is a non-selective and potent herbicide that can kill all plants by continuously generating active oxygens in the photosystems. Paraquat resistance can thus be used as an indicator of the resistance to active oxygens, and analysis concerning the mechanism of paraquat resistance in plants has been conducted (Pestic. Biochem. Physiol., 26, 22-28, 1986; Theor. Appl. Genet. 75, 850-856, 1988; and Plant Physiol., 91, 1174-1178, 1989).

0006Meanwhile, an apoptosis suppressor gene (JP Patent Publications (Kokai) No. 10-309142; No. 2000-23583; and No. 2002-300822), a gene encoding a protein homologous to aldose reductase (JP Patent Publication (Kohyo) No. 2001-523466) and a gene encoding an iron-binding protein (ferritin) (JP Patent Publication (Kohyo) No. 2001-519671) have been disclosed as genes that can impart paraquat resistance. Further, in JP Patent Publications (Kokai) No. 2002-281979 and No. 2001-95585, peroxidase derived from paraquat resistant callus is disclosed as a gene capable of imparting resistance to paraquat.

0007It had been believed that if a paraquat resistance gene that can impart strong resistance to paraquat could be isolated, it would be useful in the development of plants with high resistance to active oxygens generated under various kinds of environmental stress conditions (high and low temperatures, drought, high light intensity, salinity, air pollutant gases, pathogenic microbes and the like). However, recently it has been revealed that active oxygens fulfill an important role as a molecule regulating the growth and stress response of a plant. Therefore, to avoid influencing important characteristics such as crop yield, it is important to increase the resistance of a plant to stresses such as paraquat without affecting the growth and physiological control mechanisms of a plant dependent on active oxygens.

0008The vascular tissue is a fascicular tissue system that differentiates through each organ of pteridophytes and spermatophytes, such as the stem, leaf and root. Xylem and phloem are the components of the vascular tissue, and they function as pipes to transport water and internal substances throughout the plant. Further, the vascular cambium, which includes the interfascicular cambium and the intrafascicular cambium, is found in the vascular tissue. The vascular cambium is a site of cell proliferation, and is thus an extremely important site for the growth of a plant. Thus, the vascular tissue is a location involved in transporting water and internal substances as well as cell proliferation in a plant. Accordingly, if a gene involved in transporting water or internal substances or in cell proliferation can be introduced into a plant and expressed specifically in the vascular tissue, it will be possible to regulate the transport of water or internal substances or cell proliferation in the plant.

0009In addition, from the viewpoint of plant diseases, the vascular tissue is a site where a wilt disease fungus infecting plants of the family <i>Solanaceae</i> proliferates and transfers. When a plant virus infects a plant, the plant virus migrates a long distance from one leaf to an above leaf, and therefore the vascular tissue is also a migration site that leads to systemic infection of a plant. Accordingly, if a gene involved in proliferation or migration of a fungus or plant virus can be introduced into a plant and expressed specifically in the vascular tissue, the plant can be protected from the fungus or plant virus.

0010A trichome is a floccose outgrowth found on the surface of a leaf, stem, sepal and the like of a plant body. A trichome is involved in secretion and excretion from the surface of a plant body. For example, it is reported that when a plant is exposed to heavy metal (cadmium) stress, the number of trichomes on the surface of leaves increases and crystals containing cadmium or calcium adhere to the surface of the leaves, in other words, that cadmium is excreted by a trichome (Planta, 213 (1), 45-50, 2001, May). A trichome is also the site of first contact for a filamentous fungus, bacterium, insect or the like invading a plant. Further, as a defense against diseases and insect damages, for example, a fluid having antimicrobial activity and a feeding deterrent effect is secreted from a glandular hair or glandular trichome of rugosa rose of the family <i>Rosaceae,</i> one type of trichome. Therefore, if a gene involved in the excretion of a heavy metal or the like, or a gene involved in the secretion of a fluid having antimicrobial activity or a feeding deterrent effect can be introduced into a plant and expressed specifically in a trichome, a heavy metal can be efficiently excreted from the plant or the plant can be effectively protected against a filamentous fungus, bacterium or insect invading the plant.

0011As described above, it is desirable that specific gene expression be performed in a vascular tissue or trichome. As a method for performing specific gene expression, a method involving the use of a promoter exhibiting specific promoter activity in a vascular tissue or trichome can be considered. However, a promoter exhibiting promoter activity specifically in both a vascular tissue and a trichome has not been identified at present.

SUMMARY OF THE INVENTION

0012It is an object of the present invention to provide, for example, a paraquat resistance gene and a vascular tissue- and trichome-specific promoter by identifying and analyzing genes of <i>Arabidopsis thaliana.</i>

0013The present invention accomplishes the aforementioned object by providing the following: <ul id="ul0001" list-style="none" compact="compact"><li>(1) a gene encoding a protein of the following (a) or (b): <ul id="ul0002" list-style="none" compact="compact"><li>(a) a protein consisting of the amino acid sequence represented by SEQ ID NO: 2;</li><li>(b) a protein consisting of an amino acid sequence having a substitution, deletion or addition of one or a plurality of amino acids relative to the amino acid sequence represented by SEQ ID NO: 2 and imparting paraquat resistance;</li></ul></li><li>(2) a protein imparting paraquat resistance encoded by the gene as recited in the above (1);</li><li>(3) a recombinant vector comprising the gene as recited in the above (1);</li><li>(4) the recombinant vector according to (3), wherein the recombinant vector further comprises a foreign gene or a foreign DNA fragment;</li><li>(5) a transformant having the recombinant vector as recited in the above (3) or (4);</li><li>(6) a plant body having the recombinant vector as recited in the above (3) or (4) and having paraquat resistance;</li><li>(7) a method for screening for a transgenic plant, comprising introducing a recombinant vector as recited in the above (4) into a plant and screening for a transgenic plant on the basis of paraquat resistance as an indicator;</li><li>(8) a vascular tissue - and trichome-specific promoter comprising DNA of the following (a), (b) or (c): <ul id="ul0003" list-style="none" compact="compact"><li>(a) DNA consisting of the nucleotide sequence represented by SEQ ID NO: 3;</li><li>(b) DNA consisting of a nucleotide sequence having a substitution, deletion or addition of one or a plurality of nucleotides relative to the nucleotide sequence represented by SEQ ID NO: 3 and functioning as a vascular tissue- and trichome-specific promoter; and</li><li>(c) DNA hybridizing under stringent conditions to DNA consisting of the nucleotide sequence represented by SEQ ID NO: 3 and functioning as a vascular tissue- and trichome-specific promoter;</li></ul></li><li>(9) a recombinant vector comprising the vascular tissue- and trichome-specific promoter as recited in the above (8);</li><li>(10) the recombinant vector according to (9), wherein the recombinant vector comprises a foreign gene or a foreign DNA fragment downstream of the vascular tissue- and trichome-specific promoter;</li><li>(11) the recombinant vector according to (10), wherein the foreign gene is the gene as recited in the above (1); and</li><li>(12) a transgenic plant having the recombinant vector as recited in any one of the above (9) to (11).</li></ul>

BRIEF DESCRIPTION OF THE DRAWINGS

0014<ul id="ul0004" list-style="none" compact="compact"><li>FIG. 1 is a photograph of electrophoresis of cDNA derived from an AtMVR gene transformant;</li><li>FIG. 2A is a schematic diagram showing the location of an AtMVR gene transformant and a non-transformant in FIGS. 2B and 2C. FIG. 2B is a photograph showing the growth of an AtMVR gene transformant and a non-transformant in a 1/2 MS culture medium without paraquat. FIG. 2C is a photograph showing the growth of an AtMVR gene transformant and a non-transformant in a 1/2 MS culture medium with paraquat;</li><li>FIG. 3 is a photomicrograph of an entire transformant containing the GUS gene and an AtMVR promoter histochemically colored with GUS;</li><li>FIG. 4 is a photomicrograph of a leaf of a transformant containing the GUS gene and an AtMVR promoter histochemically colored with GUS; and</li><li>FIG. 5 is a photomicrograph of a root of a transformant containing the GUS gene and an AtMVR promoter histochemically colored with GUS.</li></ul>

DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

0015The present invention will be described in detail below.

0016The gene according to the present invention is a gene encoding the protein of the following (a) or (b): <ul id="ul0005" list-style="none" compact="compact"><li>(a) a protein consisting of the amino acid sequence represented by SEQ ID NO: 2; and</li><li>(b) a protein consisting of an amino acid sequence having a substitution, deletion or addition of one or a plurality of amino acids relative to the amino acid sequence represented by SEQ ID NO: 2 and imparting paraquat resistance.</li></ul>

0017The gene encoding the protein described in the above (a) is a gene (hereafter, referred to as "AtMVR gene") encoding a protein imparting paraquat resistance which consists of the amino acid sequence represented by SEQ ID NO: 2.

0018The present inventors performed a search on databases having the entire nucleotide sequence of <i>Arabidopsis thaliana</i> (for example, GenBank, EMBL, DDBJ, tair: The Arabidopsis Information Resource) based on the nucleotide sequence of the AtMVR gene and found that there are 13 genes homologous to the AtMVR gene (AtMVR 3-1 to AtMVR 3-13) present on the <i>Arabidopsis thaliana</i> genome. The nucleotide sequence of each of these AtMVR homologous genes and the putative amino acid sequence encoded by the relevant AtMVR homologous gene are represented by the SEQ IDD NOs. listed in Table 1 below. Table 1 also lists the results of homology analysis between the AtMVR gene and each AtMVR homologous gene. The homology analysis was conducted using BLAST P at the amino acid level. Amino acids may be classified based on the chemical properties of their side chains. In the BLOSUM62 amino acid substitution matrix (Proc. Natl. Acad. Sci., 89, 10915-10919, 1992), amino acids are classified into: an amino acid with a mercapto group (C); hydrophilic amino acids that have low molecular weight (S, T, P, A, G); acidic amino acids (N, D, E, Q); basic amino acids (H, R, K); hydrophobic amino acids that have low molecular weights (M, I, L, V); and aromatic amino acids (F, Y, W). In Table 1, the term "Identities" refers to 100% correspondence in terms of amino acids and the term "Positives" refers to the numerical value when amino acids having a positive score in the BLOSUM 62 amino acid substitution matrix are added to those having 100% correspondence (see Bioinfomatics (in Japanese), Eds. Okazaki Y. &amp; Bono H. (published by Medical Science International)). <tables id="tabl0001" num="0001"><table frame="all"><title>[Table 1]</title><tgroup cols="5" colsep="1" rowsep="1"><colspec colnum="1" colname="col1" colwidth="31.50mm" /><colspec colnum="2" colname="col2" colwidth="31.50mm" /><colspec colnum="3" colname="col3" colwidth="31.50mm" /><colspec colnum="4" colname="col4" colwidth="31.50mm" /><colspec colnum="5" colname="col5" colwidth="31.50mm" /><thead valign="top"><row><entry namest="col1" nameend="col1" align="left">Name of AtMVR homologous gene</entry><entry namest="col2" nameend="col2" align="center">Nucleotide sequence</entry><entry namest="col3" nameend="col3" align="center">Amino acid sequence</entry><entry namest="col4" nameend="col4" align="center">Identities (%)</entry><entry namest="col5" nameend="col5" align="center">Positives (%)</entry></row></thead><tbody valign="top"><row><entry namest="col1" nameend="col1" align="left">AtMVR3-1</entry><entry namest="col2" nameend="col2" align="left">SEQ ID NO: 4</entry><entry namest="col3" nameend="col3" align="left">SEQ ID NO: 5</entry><entry namest="col4" nameend="col4" align="center">57</entry><entry namest="col5" nameend="col5" align="center">70</entry></row><row><entry namest="col1" nameend="col1" align="left">AtMVR3-2</entry><entry namest="col2" nameend="col2" align="left">SEQ ID NO: 6</entry><entry namest="col3" nameend="col3" align="left">SEQ ID NO: 7</entry><entry namest="col4" nameend="col4" align="center">55</entry><entry namest="col5" nameend="col5" align="center">69</entry></row><row><entry namest="col1" nameend="col1" align="left">AtMVR3-3</entry><entry namest="col2" nameend="col2" align="left">SEQ ID NO: 8</entry><entry namest="col3" nameend="col3" align="left">SEQ ID NO: 9</entry><entry namest="col4" nameend="col4" align="center">39</entry><entry namest="col5" nameend="col5" align="center">56</entry></row><row><entry namest="col1" nameend="col1" align="left">AtMVR3-4</entry><entry namest="col2" nameend="col2" align="left">SEQ ID NO: 10</entry><entry namest="col3" nameend="col3" align="left">SEQ ID NO: 11</entry><entry namest="col4" nameend="col4" align="center">39</entry><entry namest="col5" nameend="col5" align="center">55</entry></row><row><entry namest="col1" nameend="col1" align="left">AtMVR3-5</entry><entry namest="col2" nameend="col2" align="left">SEQ ID NO: 12</entry><entry namest="col3" nameend="col3" align="left">SEQ ID NO: 13</entry><entry namest="col4" nameend="col4" align="center">37</entry><entry namest="col5" nameend="col5" align="center">54</entry></row><row><entry namest="col1" nameend="col1" align="left">AtMVR3-6</entry><entry namest="col2" nameend="col2" align="left">SEQ ID NO: 14</entry><entry namest="col3" nameend="col3" align="left">SEQ ID NO: 15</entry><entry namest="col4" nameend="col4" align="center">36</entry><entry namest="col5" nameend="col5" align="center">52</entry></row><row><entry namest="col1" nameend="col1" align="left">AtMVR3-7</entry><entry namest="col2" nameend="col2" align="left">SEQ ID NO: 16</entry><entry namest="col3" nameend="col3" align="left">SEQ ID NO: 17</entry><entry namest="col4" nameend="col4" align="center">34</entry><entry namest="col5" nameend="col5" align="center">52</entry></row><row><entry namest="col1" nameend="col1" align="left">AtMVR3-8</entry><entry namest="col2" nameend="col2" align="left">SEQ ID NO: 18</entry><entry namest="col3" nameend="col3" align="left">SEQ ID NO: 19</entry><entry namest="col4" nameend="col4" align="center">34</entry><entry namest="col5" nameend="col5" align="center">51</entry></row><row><entry namest="col1" nameend="col1" align="left">AtMVR3-9</entry><entry namest="col2" nameend="col2" align="left">SEQ ID NO: 20</entry><entry namest="col3" nameend="col3" align="left">SEQ ID NO: 21</entry><entry namest="col4" nameend="col4" align="center">37</entry><entry namest="col5" nameend="col5" align="center">58</entry></row><row><entry namest="col1" nameend="col1" align="left">AtMVR3-10</entry><entry namest="col2" nameend="col2" align="left">SEQ ID NO: 22</entry><entry namest="col3" nameend="col3" align="left">SEQ ID NO: 23</entry><entry namest="col4" nameend="col4" align="center">25</entry><entry namest="col5" nameend="col5" align="center">44</entry></row><row><entry namest="col1" nameend="col1" align="left">AtMVR3-11</entry><entry namest="col2" nameend="col2" align="left">SEQ ID NO: 24</entry><entry namest="col3" nameend="col3" align="left">SEQ ID NO: 25</entry><entry namest="col4" nameend="col4" align="center">33*</entry><entry namest="col5" nameend="col5" align="center">51*</entry></row><row><entry namest="col1" nameend="col1" align="left">AtMVR3-12</entry><entry namest="col2" nameend="col2" align="left">SEQ ID NO: 26</entry><entry namest="col3" nameend="col3" align="left">SEQ ID NO: 27</entry><entry namest="col4" nameend="col4" align="center">25</entry><entry namest="col5" nameend="col5" align="center">41</entry></row><row rowsep="1"><entry namest="col1" nameend="col1" align="left">AtMVR3-13</entry><entry namest="col2" nameend="col2" align="left">SEQ ID NO: 28</entry><entry namest="col3" nameend="col3" align="left">SEQ ID NO: 29</entry><entry namest="col4" nameend="col4" align="center">22</entry><entry namest="col5" nameend="col5" align="center">41</entry></row></tbody></tgroup><tgroup cols="5" colsep="0" rowsep="0"><colspec colnum="1" colname="col1" colwidth="31.50mm" /><colspec colnum="2" colname="col2" colwidth="31.50mm" /><colspec colnum="3" colname="col3" colwidth="31.50mm" /><colspec colnum="4" colname="col4" colwidth="31.50mm" /><colspec colnum="5" colname="col5" colwidth="31.50mm" /><tbody valign="top"><row><entry namest="col1" nameend="col5" align="justify">*The comparison with AtMVR3-11 shows the homology result for comparison with a partial sequence of AtMVR3-11.</entry></row></tbody></tgroup></table></tables>

0019As shown in Table 1, the homology of AtMVR with the 13 AtMVR homologous genes ranged from 22 to 57% for Identities and from 41 to 70% for Positives. These AtMVR homologous genes are considered to impart paraquat resistance in the same manner as the AtMVR gene.

0020Further, the AtMVR gene has homology to a senescence-associated protein, DSA 5 (GenBank accession number AF082030) (Plant Molecular Biology 40, 237-248, 1999). The result of homology analysis using BLAST X showed the protein encoded by the AtMVR gene has identity of 89% at the amino acid level to the protein encoded by DSA 5. It is reported that DSA 5 is a gene that expresses upon aging of the petal of lily (<i>Heinerocallis</i> hybrid cultivar) (Plant Molecular Biology 40, 237-248, 1999). However, since the protein encoded by DSA 5 has no homology with any known protein, it is unclear which functions the protein has. Accordingly, the AtMVR gene is a novel gene imparting paraquat resistance.

0021As used herein, the term "paraquat resistance" refers to having resistance to paraquat. More specifically, the term "paraquat-resistant plant" refers to a plant requiring a larger quantity of paraquat than a non-resistant plant in order to obtain a given effect from paraquat. Paraquat is a non-selective and potent herbicide that kills all plants by continuously generating active oxygens in the photochemical system. It is possible to confirm whether the AtMVR gene is a paraquat resistance gene imparting paraquat resistance by examining whether a transformant into which the gene was introduced can grow in the presence of paraquat.

0022The gene encoding the protein described in the above (b) is a gene encoding a protein consisting of an amino acid sequence having a substitution, deletion or addition of one or a plurality of amino acids (for example, 1 to 10, or 1 to 5) relative to the amino acid sequence represented by SEQ ID NO: 2 and imparting paraquat resistance.

0023Once the nucleotide sequence of the gene according to the present invention has been determined, it is then possible to obtain the gene according to the present invention by chemical synthesis, or by polymerase chain reaction (hereafter, referred to as "PCR") employing as a template a clone that has been cloned, or by performing hybridization employing a DNA fragment having the nucleotide sequence as a probe. Further, it is possible to synthesize a mutant of the gene according to the present invention having equivalent functions as those prior to mutation by a technique such as site-directed mutagenesis.

0024Examples of the method for introducing a mutation into the gene according to the present invention include a known method such as the Kunkel method or the gapped duplex method or a method in accordance with such methods. For example, introduction of a mutation can be performed using a kit for introducing a mutation (for example, Mutant-K (manufactured by TAKARA, Inc.), or Mutant-G (manufactured by TAKARA, Inc.)) utilizing site-directed mutagenesis or using LA PCR <i>in vitro</i> Mutagenesis series kit manufactured by TAKARA, Inc.

0025A protein imparting paraquat resistance according to the present invention is the protein encoded by the gene according to the present invention. For example, the gene according to the present invention is integrated into a vector derived from <i>Escherichia coli</i> or the like, and <i>E. coli</i> is then transformed with the obtained recombinant vector. Thereafter, the protein according to the present invention can be obtained by extracting the protein synthesized within <i>E. coli.</i>

0026Further, a recombinant vector according to the present invention is a recombinant vector comprising the gene according to the present invention. The recombinant vector according to the present invention can be obtained by inserting the gene according to the present invention into an appropriate vector. A vector used for inserting the gene according to the present invention is not particularly limited as long as it is capable of replication within a host, and examples thereof include a plasmid, a shuttle vector, and a helper plasmid. In addition, when the vector itself is not capable of replication, a DNA fragment that is capable of replication by a method such as insertion into the chromosome of a host may be used.

0027Examples of plasmid DNA include a plasmid derived from <i>E. coli</i> (pBI221 and the like, for example, pET system such as pET30b, pBR system such as pBR322 and pBR325, pUC system such as pUC118, pUC 119, pUC18 and pUC 19, pBluescript, and pBI221 ), a plasmid derived from <i>Bacillus subtilis</i> (for example, pUB110 and pTP5), a binary plasmid derived from <i>Agrobacterium tumefaciens</i> (for example, pBI system derived from pBIN19, pBI101, or pBI121), a plasmid derived from yeast (for example, YEp system such as YEp13, or YCp system such as YCp50) or the like. Examples of phage DNA include λ phage (Charon 4A, Charon 21A, EMBL3, EMBL4, λgt10, λgt11, λZAP and the like). Further, an animal virus vector such as retrovirus or vaccinia virus, a plant virus vector such as cauliflower mosaic virus, or an insect virus vector such as baculovirus can also be used.

0028To insert the gene according to the present invention into a vector, a method may be used in which cDNA of the gene according to the present invention is first cleaved using an appropriate restriction enzyme and then inserted into a restriction enzyme site or multicloning site of an appropriate vector DNA and ligated into the vector. Further, a method may be used in which a homologous region is respectively provided in one part of a vector and cDNA of the gene according to the present invention, and the vector and the cDNA are connected by an <i>in vitro</i> method using PCR or the like or an <i>in vivo</i> method using yeast or the like.

0029A recombinant vector according to the present invention can also include a foreign gene or a foreign DNA fragment in addition to the gene according to the present invention. A method for inserting a foreign gene or a foreign DNA fragment into a vector is the same as the method for inserting a DNA fragment according to the present invention into a vector. Any gene or DNA fragment may be used as a foreign gene or a foreign DNA fragment. Thus, the gene according to the present invention can be used as a selective marker gene to indicate paraquat resistance, for example, as with an antibiotic resistance gene for kanamycin or hygromycin or the like.

0030A transformant according to the present invention is a transformant having the recombinant vector according to the present invention. The transformant according to the present invention can be obtained by introducing the recombinant vector according to the present invention into a host. A host is not particularly limited as long as it is capable of expressing the gene according to the present invention, however a plant is preferred. When the host is a plant, it is possible to obtain a transgenic plant in the manner described below.

0031A "plant" to be transformed in the present invention may be any of: a whole plant, a plant organ (for example, leaf, petal, stem, root, or seed), plant tissue (for example, epidermis, phloem, parenchyma, or xylem) or a plant culture cell. Examples of the plant that can be used in the transformation include, but are not limited to, a plant belonging to the family <i>Poaceae, Brassicaceae, Solanaceae,</i> or <i>Leguminosae</i> (see below).    <i>Poaceae: Oryza sativa, Zea mays</i>    <i>Brassicaceae: Arabidopsis thaliana</i>    <i>Solanaceae: Nicotiana tabacum</i>    <i>Leguminosae: Glycine max</i>

0032The recombinant vector according to the present invention can be introduced into a plant by a conventional transformation method such as, for example, the electroporation method, Agrobacterium method, particle gun method, or PEG method.

0033For example, when using the electroporation method, the recombinant vector according to the present invention is introduced into a host by conducting the treatment using an electroporation apparatus equipped with a pulse controller under conditions of a voltage of 500 to 1600 V, at 25 to 1000 µF, for 20 to 30 msec.

0034When using the particle gun method, the whole plant, a plant organ or plant tissue itself may be used without any treatment, a section thereof may be prepared and then used, or protoplast may be prepared and used. The prepared sample can then be treated using a gene transfer device (for example, PDS-1000/He manufactured by Bio-Rad Inc.). Although the treatment conditions may vary depending on the plant or sample used, the treatment is normally conducted at a pressure of approximately 450 to 2000 psi and a distance of approximately 3 to 12 cm.

0035A method using the Ti plasmid or Ri plasmid of <i>Agrobacterium</i> takes advantage of a characteristic whereby, when a bacterium belonging to the genus <i>Agrobacterium</i> infects a plant, one part of plasmid DNA possessed by the bacterium is transferred into the genome of the plant. This method can thus be used to introduce the gene according to the present invention into a plant host. Among the bacteria belonging to the genus <i>Agrobacterium,</i> when <i>Agrobacterium tumefaciens</i> infects a plant, it causes the formation of a tumor that is referred to as "crown gall." Further, when <i>Agrobacterium rhizogenes</i> infects a plant, it incites generation of a capillary root. These are caused by a region referred to as a "T-DNA (Transferred DNA) region" of a Ti plasmid or Ri plasmid transferring into a plant at the time of infection to be integrated into the genome of the plant. Accordingly, the DNA to be integrated into a plant genome is first inserted into the T-DNA region of a Ti plasmid or Ri plasmid, and then the DNA can be integrated into the plant genome by infecting the plant host with a bacterium of the genus <i>Agrobacterium.</i>

0036Examples of the method for transforming a bacterium of the genus <i>Agrobacterium</i> into a plant host include the above described electroporation method, patent gun method and PEG method, as well as an <i>in planta</i> method. Examples of the <i>in planta</i> method include a direct Agrobacterium inoculation method and an infiltration method.

0037Tumor tissue or shoot, capillary root or the like obtained as the result of the transformation can be used without any treatment for cell culture, tissue culture or organ culture. Alternatively, it can be regenerated in a plant body by administration of a plant hormone (auxin, cytokinin, gibberellin, abscisic acid, ethylene, brassinolide or the like) of an appropriate concentration using a conventional plant tissue culture method:

0038The gene according to the present invention may also be introduced into a plant by utilizing a plant virus as a vector. Examples of the plant virus that can be used include cauliflower mosaic virus. First, the viral genome is inserted into a vector derived from <i>E. coli</i> or the like to produce a recombinant, and then the gene according to the present invention is inserted into the viral genome. The viral genome modified in this manner is subsequently cleaved from the recombinant using a restriction enzyme, and the gene according to the present invention can then be introduced into a plant host by inoculating the viral genome into the plant host.

0039In addition to introduction into a plant host as described above, the recombinant vector according to the present invention may also be introduced into bacteria belonging to the genus <i>Escherichia</i> such as <i>E. coli,</i> the genus <i>Bacillus</i> such as <i>Bacillus subtilis,</i> or the genus <i>Pseudomonas</i> such as <i>Pseudomonas putida,</i> as well as yeast such as <i>Saccharomyces cerevisiae</i> and <i>Schizosaccharomyces pombe,</i> animal cells such as COS cell or CHO cell, and insect cells such as Sf9. When using a bacterium such as <i>E. coli</i> or yeast or the like as a host, it is preferable that the recombinant vector according to the present invention is capable of autonomous replication in the bacterium and that it is comprised of a promoter, a ribosome binding sequence, a transcription termination sequence and the gene according to the present invention. It may also comprise a gene regulating the promoter.

0040The method for introducing the recombinant vector according to the present invention into a bacterium is not particularly limited as long as it is a method that can introduce DNA into a bacterium, and for example a method using calcium ion or the electroporation method may be mentioned.

0041The method for introducing the recombinant vector according to the present invention into yeast is not particularly limited as long as it is a method that can introduce DNA into yeast, and for example the electroporation method, spheroplast method and lithium acetate method may be mentioned.

0042When using an animal cell as a host, monkey cell COS-7, Vero, Chinese hamster ovary cell (CHO cell), mouse L-cells or the like can be used. The method for introducing the recombinant vector according to the present invention into an animal cell is not particularly limited as long as it is a method that can introduce DNA into an animal cell, and for example the electroporation method, calcium phosphate method and lipofection method may be mentioned.

0043When using an insect cell as a host, an Sf9 cell or the like can be used. The method for introducing the recombinant vector according to the present invention into an insect cell is not particularly limited as long as it can introduce DNA into an insect cell, and for example the calcium phosphate method, lipofection method and electroporation method may be mentioned.

0044It is possible to confirm whether or not the gene according to the present invention has been integrated into a host by using the PCR method, Southern hybridization method, Northern hybridization method or the like. For example, PCR can be conducted after preparing DNA from the transformant and designing a DNA-specific primer. Next, the amplification product is subjected to agarose gel electrophoresis, polyacrylamide gel electrophoresis or capillary electrophoresis or the like, and the product thereof is then stained with ethidium bromide, SYBR Green solution or the like. Thereafter, whether or not transformation has occurred can be confirmed by the detection of the amplification product as a single band. It is also possible to detect the amplification product after conducting PCR using a primer that has been labeled previously with a fluorescent dye or the like. In addition, a method may be employed in which the amplification product is bound to a solid phase of a microplate or the like to enable confirmation of the amplification product by fluorescence or enzyme reaction or the like.

0045A plant body according to the present invention is one having a recombinant vector comprising the gene according to the present invention and having paraquat resistance. As used herein, the term "plant body" refers to a whole plant transformed with a recombinant vector comprising the gene according to the present invention. The plant body according to the present invention can be obtained by introducing the above recombinant vector into a plant cell or the like and regenerating a transgenic plant body from the obtained transgenic plant cell. As a regeneration method, a method may be employed in which transformed cells in a callus form are transferred to a culture medium in which the type and concentration of hormones have been modified and allowed to culture, and an adventitious embryo is allowed to form to obtain a complete plant body. Examples of the culture medium to be used include LS medium and MS medium. Introduction of a recombinant vector into a plant cell or the like can be performed by a method similar to the method described above.

0046In the plant body according to the present invention, a protein imparting paraquat resistance that is encoded by the gene according to the present invention is overexpressed throughout the whole plant body. Thus, the plant body according to the present invention can have resistance to paraquat.

0047A method of screening for transgenic plants according to the present invention is a method in which the recombinant vector according to the present invention is introduced into plants and paraquat resistance is used as an indicator to screen for transgenic plants. Transformation can be verified by employing the gene according to the present invention as a selective marker gene to indicate paraquat resistance. Examples of the screening method include a method in which plants transformed by the recombinant vector according to the present invention are grown in a paraquat-containing medium and the screening is carried out based on variations in the life and death as well as growth of the plants. The concentration of paraquat used for the screening may vary depending on the species and size of plants and the like, however, for example, when <i>Arabidopsis thaliana</i> is used as a host, paraquat may be present in a medium at a concentration of preferably 0.1 to 3.0 µM, more preferably 1.0 to 3.0 µM, and most preferably 3.0 µM. A non-transgenic plant, i.e., a wild-type plant, develops chlorosis and dies in a paraquat-containing medium. In contrast, a plant transformed with the recombinant vector according to the present invention remains green even in a paraquat-containing medium. Thus, it is possible to verify a clear difference in growth in a paraquat-containing medium between a non-transgenic plant and a plant transformed with the recombinant vector according to the present invention.

0048When employing antibiotic resistance or herbicide resistance as an indicator, false positivity may be observed at the screening stage because of the existence of a difference in sensitivity among the plant. In contrast, paraquat is a non-selective and potent herbicide that can kill all plants. Consequently, in the method of screening transgenic plants according to the present invention, false positivity is not observed in the screening stage. Further, according to the method of screening transgenic plants according to the present invention, resistance can be effectively confirmed at an early stage of growth.

0049The promoter according to the present invention is a vascular tissue- and trichome-specific promoter comprising the DNA of the following (a), (b) or (c): <ul id="ul0006" list-style="none" compact="compact"><li>(a) DNA consisting of the nucleotide sequence represented by SEQ ID NO: 3;</li><li>(b) DNA consisting of a nucleotide sequence having a substitution, deletion or addition of one or a plurality of nucleotides relative to the nucleotide sequence represented by SEQ ID NO: 3 and functioning as a vascular tissue- and trichome-specific promoter; and</li><li>(c) DNA hybridizing under stringent conditions to DNA consisting of the nucleotide sequence represented by SEQ ID NO: 3 and functioning as a vascular tissue- and trichome-specific promoter.</li></ul>

0050The vascular tissue- and trichome-specific promoter described in the above (a) is a vascular tissue- and trichome-specific promoter found in an untranslated region on the 5'-upstream side of the AtMVR gene and consists of the nucleotide sequence represented by SEQ ID NO: 3. The promoter described in (a) can be determined by performing a search based on approximately 3,000 nucleotides on the 5'-upstream side of the AtMVR gene on a database having the complete nucleotide sequence for <i>Arabidopsis thaliana.</i>

0051As used herein, the term "vascular tissue- and trichome-specific promoter" refers to a promoter exhibiting activity specific to a vascular tissue and trichome of a plant. The term "vascular tissue" refers to a fascicular tissue system that differentiates through each organ of pteridophytes and spermatophytes, such as the stem, leaf, and root. Xylem and phloem are the components of the vascular tissue, and they function as pipes to transport water and internal substances throughout the plant. Meanwhile, the term "trichome" refers to a floccose outgrowth existing on the surface of a leaf, stem, or sepal of a plant body. A trichome participates in secretion and excretion from the plant body surface.

0052The activity of a vascular tissue- and trichome-specific promoter can be determined in accordance with a conventional method. For example, an expression vector having a reporter gene operably linked thereto downstream of a promoter may be constructed. Next, an appropriate plant is transformed with the expression vector. The obtained transformant is then cultured under predetermined conditions, and the expression amount of the reporter gene in a vascular tissue and trichome may be determined at the mRNA or protein level to enable the measurement of promoter activity under the relevant conditions. Further, when the reporter gene is the β-Glucuronidase (GUS) gene, the specificity of promoter activity in a vascular tissue and trichome can be determined by observing the histochemical coloring caused by the expressed GUS.

0053For example, as a method of the histochemical coloring using GUS, a method may be mentioned in which a reaction mixture containing 5-brome-4-chloro-3-indolyl-β-D-glucuronide (X-Gluc) as a GUS substrate is added to a tissue of a transformant in which the GUS gene has been introduced. When the GUS gene is expressed, X-Gluc is de-esterified to generate an indoxyl derivative monomer, and this monomer is oxidation-polymerized with air to form a blue indigotin pigment. In a transformed cell or tissue, this blue pigment accumulates to exhibit a blue color.

0054Further, a specified untranslated region on the 5'-upstream side of the AtMVR gene can be readily obtained by conducting PCR employing genome extracted from <i>Arabidopsis thaliana</i> as a template and using primers that are complementary to the nucleotide sequences on both ends of the region.

0055The promoter according to the present invention may be the nucleotide sequence represented by SEQ ID NO: 3, more specifically, the entire untranslated region on the 5'-upstream side, or it may be one part of DNA consisting of the nucleotide sequence represented by SEQ ED NO: 3 in so far as it exhibits a function as a vascular tissue- and trichome-specific promoter.

0056The vascular tissue- and trichome-specific promoter described in the above (b) consists of a nucleotide sequence having a substitution, deletion or addition of one or a plurality of nucleotides (for example, 1 to 10, or 1 to 5) relative to the nucleotide sequence represented by SEQ ID NO: 3 and functions as a vascular tissue- and trichome-specific promoter.

0057The vascular tissue- and trichome-specific promoter described in the above (c) hybridizes under stringent conditions to DNA consisting of the nucleotide sequence represented by SEQ ID NO: 3 and functions as a vascular tissue- and trichome-specific promoter.

0058As used herein, the term "stringent conditions" refers to, for example, when using probe DNA labeled with phosphorus-32, hybridization in a hybridization solution consisting of 5x SSC (0.75 M NaCl, 0.75 M sodium citrate), 5x Denhardt's reagent (0.1% Ficoll, 0.1% polyvinylpyrrolidone, 0.1% bovine serum albumin) and 0.1% sodium dodecyl sulphate (SDS) at a temperature between 45 and 68°C, preferably 60 to 68°C. Further, in the washing step, washing is performed in a washing solution consisting of 2x SSC and 0.1% SDS at a temperature between 45 and 55°C, and more preferably in a washing solution consisting of 0.1x SSC and 0.1% SDS at a temperature between 45 and 55°C. When using probe DNA enzymatically labelled using the AlkPhos direct labeling module kit (Amersham Biotech), hybridization may be conducted in a hybridization solution (containing 0.5 M NaCl and 4% blocking reagent) having the composition described in the manual accompanying the kit at a temperature between 55 to 75°C. Further, in a washing step, washing may be conducted in a primary washing solution (containing 2 M urea) in accordance with the instructions in the manual accompanying the kit at a temperature between 55 to 75°C, and in a secondary washing solution at room temperature. Other detection techniques may also be used, in which case the conditions may be the standard conditions for the relevant detection technique.

0059Once the nucleotide sequence of the promoter according to the present invention has been determined, it is then possible to obtain the promoter according to the present invention by chemical synthesis, or by PCR employing a cloned probe as a template, or by performing hybridization employing a DNA fragment having the nucleotide sequence as a probe. Further, it is possible to synthesize a mutant of the promoter according to the present invention having equivalent functions as those prior to mutation by a technique such as site-directed mutagenesis.

0060Examples of the method for introducing a mutation into the promoter according to the present invention include a known method such as the Kunkel method or the gapped duplex method or a method in accordance with such methods. For example, the introduction of a mutation can be performed using a kit for introducing a mutation (for example, Mutant-K or Mutant-G (both manufactured by TAKARA, Inc.) utilizing site-directed mutagenesis or using LA PCR <i>in vitro</i> Mutagenesis series kit manufactured by TAKARA, Inc.

0061A recombinant vector according to the present invention comprising the promoter according to the present invention can be obtained by inserting the promoter according to the present invention into an appropriate vector. A vector for inserting the promoter according to the present invention is not particularly limited as long as it is capable of replication within a host, and examples thereof include a plasmid, a shuttle vector, and a helper plasmid. In addition, when the vector itself is not capable of replication, a DNA fragment that is capable of replication by a method such as insertion into the chromosome of a host may be used.

0062Examples of plasmid DNA include a plasmid derived from <i>E. coli</i> (pBI221 and the like, for example, pET system such as pET30b, pBR system such as pBR322 and pBR325, pUC system such as pUC118, pUC 119, pUC18 and pUC 19, pBluescript, and pBI221), a plasmid derived from <i>Bacillus subtilis</i> (for example, pUB110 and pTP5), a binary plasmid derived from <i>Agrobacterium tumefaciens</i> (for example, pBI system derived from pBIN19, pBI101, or pBI121), a plasmid derived from yeast (for example, YEp system such as YEp13, or YCp system such as YCp50) or the like. Examples of phage DNA include λ phage (Charon 4A, Charon 21A, EMBL3, EMBL4, λgt10, λgt11, λZAP and the like). Further, an animal virus vector such as retrovirus or vaccinia virus, or an insect virus vector such as baculovirus can also be used.

0063To insert the promoter according to the present invention into a vector, a method may be used in which purified DNA is first cleaved with an appropriate restriction enzyme and then inserted into a restriction enzyme site or multicloning site of an appropriate vector DNA and ligated to the vector. Further, a method may also be used in which a homologous region is respectively provided in one part of a vector and the promoter according to the present invention, and the vector and promoter are ligated by an <i>in vitro</i> method using PCR or the like or an <i>in vivo</i> method using yeast or the like.

0064The recombinant vector according to the present invention comprising the promoter according to the present invention can further include a foreign gene or a foreign DNA fragment that is inserted downstream of the promoter according to the present invention. A method for inserting a foreign gene or a foreign DNA fragment is the same as a method for inserting the promoter according to the present invention into a vector.

0065In the recombinant vector according to the present invention comprising the promoter according to the present invention, examples of a foreign gene to be inserted downstream of the promoter according to the present invention include any foreign gene, and specific examples include a gene involved in transport of water or internal substances or in cell proliferation, a gene involved in proliferation or transport of bacteria or a plant virus, a gene involved in discharge of a heavy metal or the like, or a gene involved in secretion of a liquid having antimicrobial activity or a feeding deterrent effect. More specifically, the gene may be a gene for transporter or pump, a gene encoding a PR-protein (Pathogenesis related protein) (chitinase, peroxidase or the like), a defensin family gene, a phytoalexin synthesis gene or a repellant pheromone synthesis gene of a pest insect or the like. As further examples of a foreign gene, the gene according to the present invention described above, the AtMVR gene, may be mentioned.

0066Examples of the foreign DNA fragment to be inserted downstream of the promoter according to the present invention include antisense RNA or a ribozyme in which the RNA itself is functioning.

0067The transgenic plant according to the present invention is a transgenic plant having the recombinant vector according to the present invention comprising the promoter according to the present invention. The transgenic plant according to the present invention can be obtained by introducing the recombinant vector according to the present invention comprising the promoter according to the present invention into a plant. A transgenic plant can be obtained in the manner described below.

0068A "plant" to be transformed in the present invention may be any of: a whole plant, a plant organ having a vascular tissue and/or trichome (for example, leaf, petal, stem, root, or seed), plant tissue (for example, epidermis, phloem, parenchyma, or xylem) or a plant culture cell. Examples of the plant that can be used in the transformation include, but are not limited to, a plant belonging to the family <i>Poaceae, Brassicaceae, Solaiiaceae,</i> or <i>Leguminosae</i> (see below).    <i>Poaceae: Oryza sativa, Zea mays</i>    <i>Brassicaceae: Arabidopsis thaliana</i>    <i>Solanaceae: Nicotiana tabacum</i>    <i>Leguminosae: Glycine max</i>

0069The recombinant vector according to the present invention comprising the promoter according to the present invention can be introduced into a plant by a conventional transformation method such as, for example, the electroporation method, Agrobacterium method, particle gun method, or PEG method.

0070For example, when using the electroporation method the recombinant vector according to the present invention comprising the promoter according to the present invention is introduced into a host by the treatment using an electroporation apparatus equipped with a pulse controller under conditions of a voltage of 500 to 1600 V, at 25 to 1000 µF, for 20 to 30 msec.

0071When using the particle gun method, the whole plant, a plant organ or plant tissue itself may be used without any treatment, a section thereof may be prepared and then used, or protoplast may be prepared and used. The prepared sample can then be treated using a gene transfer device (for example, PDS-1000/He manufactured by Bio-Rad Inc.). Although the treatment conditions may vary depending on the plant or sample used, the treatment is normally conducted at a pressure of approximately 450 to 2000 psi and a distance of approximately 3 to 12 cm.

0072The method using the Ti plasmid or Ri plasmid of <i>Agrobacterium</i> takes advantage of a characteristic whereby, when a bacterium belonging to the genus <i>Agrobacterium</i> infects a plant, one part of plasmid DNA possessed by the bacterium is transferred into the genome of the plant. This method can thus be used to introduce the promoter according to the present invention and a foreign gene or foreign DNA fragment into a plant host. Among the bacteria belonging to the genus <i>Agrobacterium,</i> when <i>Agrobacterium tumefaciens</i> infects a plant, it causes the formation of a tumor that is referred to as "crown gall." Further, when <i>Agrobacterium rhizogenes</i> infects a plant, it incites the generation of a capillary root. These are caused by a region referred to as a "T-DNA (Transferred DNA) region" of a Ti plasmid or Ri plasmid transferring into a plant at the time of infection to be integrated into the genome of the plant. Accordingly, the DNA to be integrated into a plant genome is first inserted into the T-DNA region of a Ti plasmid or Ri plasmid, and then the DNA can be integrated into the plant genome by infecting the plant host with a bacterium of the genus <i>Agrobacterium.</i>

0073Examples of the method for transforming a bacterium of the genus <i>Agrobacterium</i> into a plant host include the above described electroporation method, particle gun method and PEG method, as well as an <i>in planta</i> method. Examples of the <i>in planta</i> method include a direct Agrobacterium inoculation method and an infiltration method.

0074The tumor tissue or shoot, capillary root or the like obtained as the result of transformation can be used without any treatment for cell culture, tissue culture or organ culture. Alternatively, it can be regenerated in a plant body by administration of a plant hormone (auxin, cytokinin, gibberellin, abscisic acid, ethylene, brassinolide or the like) of an appropriate concentration using a plant tissue culture method known in the prior art.

0075Further, the promoter according to the present invention and a foreign gene or foreign DNA fragment can be introduced into a plant by utilizing a plant virus as a vector. Examples of the plant virus that can be used herein include cauliflower mosaic virus. First, the viral genome is inserted into a vector derived from <i>E. coli</i> or the like to produce a recombinant, and then the promoter according to the present invention and the foreign gene or foreign DNA fragment is inserted into the viral genome. The viral genome modified in this manner is subsequently cleaved from the recombinant using a restriction enzyme, and the promoter according to the present invention and the foreign gene or foreign DNA fragment can be introduced into a plant host by inoculating the viral genome into the plant host.

0076The transgenic plant according to the present invention produced in the above manner can specifically express the foreign gene or foreign DNA fragment in a vascular tissue and trichome using the promoter according to the present invention.

0077The vascular tissue is a location involved in transporting water and internal substances as well as cell proliferation in a plant. Thus, when a gene involved in transporting water or internal substances or in cell proliferation is introduced as a foreign gene into the transgenic plant according to the present invention, the transport of water and internal substances or cell proliferation in the plant can be regulated. The vascular tissue is also a site where wilt disease fungus infecting plants of the family <i>Solanaceae</i> proliferates and transfers. When a plant virus infects a plant, the plant virus migrates a long distance from one leaf to an above leaf and therefore the vascular tissue is also a migration site that leads to systemic infection of a plant. Thus, when a gene involved in proliferation or migration of a fungus or plant virus is introduced as a foreign gene into the transgenic plant according to the present invention, the plant can be protected from the fungus or plant virus.

0078Meanwhile, a trichome is involved in secretion and excretion from the surface of a plant body. For example, it is reported that when a plant is exposed to heavy metal (cadmium) stress, the number of trichomes on the surface of leaves increases and crystals containing cadmium or calcium adhere to the surface of the leaves, in other words, that cadmium is excreted by a trichome (Planta, 213 (1), 45-50, 2001, May). A trichome is also the site of first contact for a filamentous fungus, bacterium, insect or the like invading a plant. Further, as a defense against diseases and insect damages, for example, a fluid having antimicrobial activity and a feeding deterrent effect is secreted from a glandular hair or glandular trichome of rugosa rose of the family <i>Rosaceae,</i> one type of trichome. Therefore, when a gene involved in the excretion of a heavy metal or the like, or a gene involved in secretion of a fluid having antimicrobial activity or a feeding deterrent effect is introduced as a foreign gene into the transgenic plant according to the present invention, heavy metal can be efficiently excreted from the plant or the plant can be effectively protected against a filamentous fungus, bacterium or insect invading the plant.

0079Further, when the gene according to the present invention is introduced as a foreign gene into the transgenic plant according to the present invention, resistance to paraquat can be imparted by promoting the transportation and excretion and the like of paraquat incorporated in the plant body.

[Examples]

0080The present invention will be explained in detail further below with reference to the following examples. However, the examples are not intended to limit the technical scope of the invention.

[Example 1] Isolation of paraquat resistance gene

0081In this example, Weigel T-DNA lines acquired from Nottingham Arabidopsis Stock Center (http://nasc.nott.ac.uk/) were used as activation tag lines of <i>Arabidopsis thaliana.</i>

(1) Screening of individuals capable of growing in paraquat-containing medium using activation-tagged lines of <i>Arabidopsis thaliana</i> (Weigel T-DNA lines)

0082Seeds of Weigel T-DNA lines were sterilely inoculated in 1/2 MS agar (1%) culture medium (2.3 g/l of Murashige and Skoog Plant Salt Mixture (manufactured by Wako Pure Chemical Industries Ltd.), 1.5 mg/l of thiamine hydrochloride, 2.5 mg/l of nicotinic acid, 0.25 mg/l of pyridoxine hydrochloride, 1.5% of sucrose, 1% of agar) containing 3 µM of paraquat (methyl viologen, manufactured by Sigma Chemical Co.), and cultured at 22°C under irradiation of light of 60 µE/m²/s (cycle of 16 hrs photoperiod/8 hrs dark period). Approximately 10 days after culture, individuals growing in the paraquat-containing medium were screened.

(2) Estimation of insertion sites of T-DNA from the screened activation-tagged lines by the TAIL-PCR method

0083Seeds of Weigel T-DNA lines from which screened individuals originated were planted in a pot containing vermiculite (manufactured by Asahi Kagaku Kogyo Co., Ltd.) and grown for approximately one month at 23°C under a light intensity of 100 µE/m²/s with a photoperiod condition of 16 hrs photoperiod/8 hrs dark period.

0084Genome DNA was prepared from leaves of cultivated individuals using the DNeasy Plant Mini Kit (manufactured by QIAGEN), and three types of specific primers (TL1: SEQ ID NO: 31; TL2: SEQ ID NO: 32; TL3: SEQ ID NO: 33) were designed for the vicinity of a T-DNA left sequence (T-DNA left border: SEQ ID NO: 30) of an activation-tagging vector (pSK1015: GenBank accession No. AF187951) used with the Weigel T-DNA lines. TAIL-PCR (Shokubutsu No PCR Jikken Purotokoru (Protocols of PCR Experiments for Plants), (Eds. Shimamoto K. &amp; Sasaki T.), New Edition, 2000, pp 83-89, Shujunsha Co., Ltd., Tokyo; Genomics, 25, 674-681, 1995; Plant J., 8, 457-463, 1995) was then performed using the specific primers and a random primer 1 (SEQ ID NO: 34) and the PCR reaction mixture and reaction conditions described below to amplify genome DNA bordering the T-DNA. In SEQ ID NO: 34, n represents a, g, c, or t (location: 1 and 11), s represents g or c (location: 7), and w represents a or t (location: 8 and 13).

0085The composition of the reaction mixture and the PCR conditions for the first-round PCR are listed in tables 2 and 3. <tables id="tabl0002" num="0002"><table frame="all"><title>[Table 2]</title><tgroup cols="2" colsep="1" rowsep="0"><colspec colnum="1" colname="col1" colwidth="78.75mm" /><colspec colnum="2" colname="col2" colwidth="78.75mm" /><tbody valign="top"><row><entry namest="col1" nameend="col1" align="left">Template (genome DNA)</entry><entry namest="col2" nameend="col2" align="left">10 ng</entry></row><row><entry namest="col1" nameend="col1" align="left">10x PCR buffer (manufactured by TAKARA BIO Inc.)</entry><entry namest="col2" nameend="col2" align="left">2 µl</entry></row><row><entry namest="col1" nameend="col1" align="left">2.5 mM dNTPs (manufactured by TAKARA BIO Inc.)</entry><entry namest="col2" nameend="col2" align="left">1.6 µl</entry></row><row><entry namest="col1" nameend="col1" align="left">First specific primer (TL1: SEQ ID NO: 31)</entry><entry namest="col2" nameend="col2" align="left">3 pmol</entry></row><row><entry namest="col1" nameend="col1" align="left">Random primer 1 (SEQ ID NO: 34)</entry><entry namest="col2" nameend="col2" align="left">80 pmol</entry></row><row rowsep="1"><entry namest="col1" nameend="col1" align="left">AmpliTaq (manufactured by Applied Biosystems)</entry><entry namest="col2" nameend="col2" align="left">0.8 units</entry></row><row rowsep="1"><entry namest="col1" nameend="col1" align="left">Total volume</entry><entry namest="col2" nameend="col2" align="left">20 µl</entry></row></tbody></tgroup></table></tables><tables id="tabl0003" num="0003"><table frame="all"><title>[Table 3]</title><tgroup cols="2" colsep="1" rowsep="0"><colspec colnum="1" colname="col1" colwidth="78.75mm" /><colspec colnum="2" colname="col2" colwidth="78.75mm" /><tbody valign="top"><row><entry namest="col1" nameend="col1" align="left">#1</entry><entry namest="col2" nameend="col2" align="left">94°C (1 min)/95°C (1 min)</entry></row><row><entry namest="col1" nameend="col1" align="left">#2</entry><entry namest="col2" nameend="col2" align="left">94°C (1 min)/65°C (1 min)/72°C (3 min) x 5 cycles</entry></row><row><entry namest="col1" nameend="col1" align="left">#3</entry><entry namest="col2" nameend="col2" align="left">94°C (1 min)/25°C (3 min) → to 72°C at 3 min/72°C (3 min) x 1 cycle</entry></row><row><entry namest="col1" nameend="col1" align="left">#4</entry><entry namest="col2" nameend="col2" align="left">94°C (30 sec)/68°C (1 min)/72°C (3 min)</entry></row><row><entry namest="col1" nameend="col1" /><entry namest="col2" nameend="col2" align="left">94°C (30 sec)/68°C (1 min)/72°C (3 min)</entry></row><row><entry namest="col1" nameend="col1" /><entry namest="col2" nameend="col2" align="left">94°C (30 sec)/44°C (1 min)/72°C (3 min) x 14 cycles</entry></row><row rowsep="1"><entry namest="col1" nameend="col1" align="left">#5</entry><entry namest="col2" nameend="col2" align="left">72°C (5 min)</entry></row></tbody></tgroup></table></tables>

0086The composition of the reaction mixture and the PCR conditions for the second-round PCR are listed in tables 4 and 5. <tables id="tabl0004" num="0004"><table frame="all"><title>[Table 4]</title><tgroup cols="2" colsep="1" rowsep="0"><colspec colnum="1" colname="col1" colwidth="78.75mm" /><colspec colnum="2" colname="col2" colwidth="78.75mm" /><tbody valign="top"><row><entry namest="col1" nameend="col1" align="left">Template (a 50-fold dilution of product of first-round PCR)</entry><entry namest="col2" nameend="col2" align="left">1 µl</entry></row><row><entry namest="col1" nameend="col1" align="left">10x PCR buffer</entry><entry namest="col2" nameend="col2" align="left">2 µl</entry></row><row><entry namest="col1" nameend="col1" align="left">250 µM dNTPs</entry><entry namest="col2" nameend="col2" align="left">2 µl</entry></row><row><entry namest="col1" nameend="col1" align="left">Second specific primer (TL2: SEQ ID NO: 32)</entry><entry namest="col2" nameend="col2" align="left">4 pmol</entry></row><row><entry namest="col1" nameend="col1" align="left">Random primer 1 (SEQ ID NO: 34)</entry><entry namest="col2" nameend="col2" align="left">60 pmol</entry></row><row rowsep="1"><entry namest="col1" nameend="col1" align="left">AmpliTaq</entry><entry namest="col2" nameend="col2" align="left">0.6 units</entry></row><row rowsep="1"><entry namest="col1" nameend="col1" align="left">Total volume</entry><entry namest="col2" nameend="col2" align="left">20 µl</entry></row></tbody></tgroup></table></tables><tables id="tabl0005" num="0005"><table frame="all"><title>[Table 5]</title><tgroup cols="2" colsep="1" rowsep="0"><colspec colnum="1" colname="col1" colwidth="78.75mm" /><colspec colnum="2" colname="col2" colwidth="78.75mm" /><tbody valign="top"><row><entry namest="col1" nameend="col1" align="left">#6</entry><entry namest="col2" nameend="col2" align="left">94°C (30 sec)/64°C (1 min)/72°C (3 min)</entry></row><row><entry namest="col1" nameend="col1" /><entry namest="col2" nameend="col2" align="left">94°C (30 sec)/64°C (1 min)/72°C (3 min)</entry></row><row><entry namest="col1" nameend="col1" /><entry namest="col2" nameend="col2" align="left">94°C (30 sec)/44°C (1 min)/72°C (3 min) × 10 cycles</entry></row><row rowsep="1"><entry namest="col1" nameend="col1" align="left">#5</entry><entry namest="col2" nameend="col2" align="left">72°C (5 min)</entry></row></tbody></tgroup></table></tables>

0087The composition of the reaction mixture and the PCR conditions for the third-round PCR are listed in tables 6 and 7. <tables id="tabl0006" num="0006"><table frame="all"><title>[Table 6]</title><tgroup cols="2" colsep="1" rowsep="0"><colspec colnum="1" colname="col1" colwidth="78.75mm" /><colspec colnum="2" colname="col2" colwidth="78.75mm" /><tbody valign="top"><row><entry namest="col1" nameend="col1" align="left">Template (a 50-fold dilution of product of second-round PCR)</entry><entry namest="col2" nameend="col2" align="left">1 µl</entry></row><row><entry namest="col1" nameend="col1" align="left">10x PCR buffer</entry><entry namest="col2" nameend="col2" align="left">10 µl</entry></row><row><entry namest="col1" nameend="col1" align="left">2.5 mM dNTPs</entry><entry namest="col2" nameend="col2" align="left">1 µl</entry></row><row><entry namest="col1" nameend="col1" align="left">Third specific primer (TL3: SEQ ID NO: 33)</entry><entry namest="col2" nameend="col2" align="left">30 pmol</entry></row><row><entry namest="col1" nameend="col1" align="left">Random primer 1 (SEQ ID NO: 34)</entry><entry namest="col2" nameend="col2" align="left">300 pmol</entry></row><row rowsep="1"><entry namest="col1" nameend="col1" align="left">AmpliTaq</entry><entry namest="col2" nameend="col2" align="left">3 units</entry></row><row rowsep="1"><entry namest="col1" nameend="col1" align="left">Total volume</entry><entry namest="col2" nameend="col2" align="left">100 µl</entry></row></tbody></tgroup></table></tables><tables id="tabl0007" num="0007"><table frame="all"><title>[Table 7]</title><tgroup cols="2" colsep="1" rowsep="0"><colspec colnum="1" colname="col1" colwidth="78.75mm" /><colspec colnum="2" colname="col2" colwidth="78.75mm" /><tbody valign="top"><row><entry namest="col1" nameend="col1" align="left">#7</entry><entry namest="col2" nameend="col2" align="left">94°C (1 min)/44°C (1 min)/72°C (3 min) × 20 cycles</entry></row><row rowsep="1"><entry namest="col1" nameend="col1" align="left">#5</entry><entry namest="col2" nameend="col2" align="left">72°C (5 min)</entry></row></tbody></tgroup></table></tables>

0088Next, after subjecting the reaction products from the second-round PCR and third-round PCR to electrophoresis on agarose gel, the presence or absence of amplification and the specificity of the reaction products were verified.

0089Further, using the specific primer TL3 (SEQ ID NO: 33), the amplification product of the third-round PCR was directly sequenced using the ABI PRISM Dye Terminator Cycle Sequencing Kit (Applied Biosystems) and the nucleotide sequence was then determined using the ABI PRISM 310 genetic analyzer (Applied Biosystems). As a result, 278-bp sequence information was obtained (SEQ ID NO: 35). In SEQ ID NO: 35, n represents a, g, c, or t (location: 13, 35, 73, 108, 156, 190, 198 and 201). A search was performed for the obtained sequence on databases having the entire nucleotide sequence of <i>Arabidopsis thaliana,</i> and it was found that the insertion site is located at 77240 bp of BAC clone F17I23.

(3) Isolation of cDNA of paraquat resistance gene

0090Seeds of <i>Arabidopsis thaliana</i> (<i>Arabidopsis thaliana</i> ecotype Columbia (Col-0)) were planted in a pot containing vermiculite (Asahi Kagaku Kogyo Co., Ltd.) and allowed to grow for approximately one month at 23°C under a light intensity of 100 µE/m²/s with a photoperiod condition of 16 hrs photoperiod/8 hrs dark period.

0091After growing, leaves of individuals were frozen using liquid nitrogen. Subsequently, total RNA was extracted using the RNeasy Plant Mini Kit (manufactured by QIAGEN). Thereafter, cDNA was synthesized from the extracted total RNA using the ProSTAR First Strand RT-PCR Kit (manufactured by STRATAGEN).

0092Based on the sequence of a putative open reading frame (ORF) gene present within an adjacent 10 kb of a structural gene having the nucleotide sequence (SEQ ID NO: 35) obtained in the above (2), a primer 141dF (SEQ ID NO: 36) and a primer 141dR (SEQ ID NO: 37) were designed for the putative structural gene, and PCR was then performed using these primers and the following reaction mixture (Table 8) containing Takara EX-Taq (manufactured by TAKARA BIO Inc.) employing the above synthesized cDNA as a template. <tables id="tabl0008" num="0008"><table frame="all"><title>[Table 8]</title><tgroup cols="2" colsep="1" rowsep="0"><colspec colnum="1" colname="col1" colwidth="78.75mm" /><colspec colnum="2" colname="col2" colwidth="78.75mm" /><tbody valign="top"><row><entry namest="col1" nameend="col1" align="left">Template (cDNA)</entry><entry namest="col2" nameend="col2" align="left">50 ng</entry></row><row><entry namest="col1" nameend="col1" align="left">10x Ex Taq buffer (TAKARA BIO Inc.)</entry><entry namest="col2" nameend="col2" align="left">2 µl</entry></row><row><entry namest="col1" nameend="col1" align="left">dNTPs</entry><entry namest="col2" nameend="col2" align="left">200 µM</entry></row><row><entry namest="col1" nameend="col1" align="left">Each primer</entry><entry namest="col2" nameend="col2" align="left">0.2 µM</entry></row><row rowsep="1"><entry namest="col1" nameend="col1" align="left">Takara EX-Taq</entry><entry namest="col2" nameend="col2" align="left">1 unit</entry></row><row rowsep="1"><entry namest="col1" nameend="col1" align="left">Total volume</entry><entry namest="col2" nameend="col2" align="left">20 µl</entry></row></tbody></tgroup></table></tables>

0093Thirty cycles of 94°C (30 sec)/55°C (30 sec)/72°C (60 sec) were employed as the reaction conditions.

0094The amplification product was cloned into the pGEM-T Easy vector (manufactured by Promega), and the nucleotide sequence was then determined using the ABI PRISM 310 genetic analyzer (Applied Biosystems). As a result, a cDNA fragment of 857 bp was obtained (SEQ ID NO: 1). This cDNA fragment was designated as AtMVR gene, and the pGEM-T Easy vector containing AtMVR gene was designated as pAtMVR. The amino acid sequence encoded by the AtMVR gene is shown in SEQ ID NO: 2.

[Example 2] Search for AtMVR homologous gene with respect to AtMVR gene

0095The search was made on databases having the entire nucleotide sequence of <i>Arabidopsis thaliana</i> based on the nucleotide sequence of the AtMVR gene and found that in addition to the nucleotide sequence of the AtMVR gene there are 13 AtMVR homologous genes on the <i>Arabidopsis thaliana</i> genome.

0096The respective AtMVR homologous genes were designated as AtMVR3-1 to AtMVR3-13. The nucleotide sequence of each of the AtMVR homologous genes and the putative amino acid sequence encoded by the relevant AtMVR homologous gene are shown by the SEQ ID NOs. listed in Table 9 below. Table 9 also lists the results of homology analysis between the AtMVR gene and each AtMVR homologous gene. The homology analysis was conducted using BLAST P at the amino acid level. The term "Identities" refers to 100% correspondence in terms of amino acids. Amino acids may be classified based on the chemical properties of their side chains. In the BLOSUM62 amino acid substitution matrix, amino acids are classified into: an amino acid with a mercapto group (C); hydrophilic amino acids that have low molecular weights (S, T, P, A, G); acidic amino acids (N, D, E, Q); basic amino acids (H, R, K); hydrophobic amino acids that have low molecular weights (M, I, L, V); and aromatic amino acids (F, Y, W). In Table 9, the term "Identities" refers to 100% correspondence in terms of amino acids and the term "Positives" refers to the numerical value when amino acids having a positive score in the BLOSUM 62 amino acid substitution matrix are added to those having 100% correspondence. <tables id="tabl0009" num="0009"><table frame="all"><title>[Table 9]</title><tgroup cols="5" colsep="1" rowsep="1"><colspec colnum="1" colname="col1" colwidth="31.50mm" /><colspec colnum="2" colname="col2" colwidth="31.50mm" /><colspec colnum="3" colname="col3" colwidth="31.50mm" /><colspec colnum="4" colname="col4" colwidth="31.50mm" /><colspec colnum="5" colname="col5" colwidth="31.50mm" /><thead valign="top"><row><entry namest="col1" nameend="col1" align="left">Name of AtMVR homologous gene</entry><entry namest="col2" nameend="col2" align="center">Nucleotide sequence</entry><entry namest="col3" nameend="col3" align="center">Amino acid sequence</entry><entry namest="col4" nameend="col4" align="center">Identities (%)</entry><entry namest="col5" nameend="col5" align="center">Positives (%)</entry></row></thead><tbody valign="top"><row><entry namest="col1" nameend="col1" align="left">AtMVR3-1</entry><entry namest="col2" nameend="col2" align="left">SEQ ID NO: 4</entry><entry namest="col3" nameend="col3" align="left">SEQ ID NO: 5</entry><entry namest="col4" nameend="col4" align="center">57</entry><entry namest="col5" nameend="col5" align="center">70</entry></row><row><entry namest="col1" nameend="col1" align="left">AtMVR3-2</entry><entry namest="col2" nameend="col2" align="left">SEQ ID NO: 6</entry><entry namest="col3" nameend="col3" align="left">SEQ ID NO: 7</entry><entry namest="col4" nameend="col4" align="center">55</entry><entry namest="col5" nameend="col5" align="center">69</entry></row><row><entry namest="col1" nameend="col1" align="left">AtMVR3-3</entry><entry namest="col2" nameend="col2" align="left">SEQ ID NO: 8</entry><entry namest="col3" nameend="col3" align="left">SEQ ID NO: 9</entry><entry namest="col4" nameend="col4" align="center">39</entry><entry namest="col5" nameend="col5" align="center">56</entry></row><row><entry namest="col1" nameend="col1" align="left">AtMVR3-4</entry><entry namest="col2" nameend="col2" align="left">SEQ ID NO: 10</entry><entry namest="col3" nameend="col3" align="left">SEQ ID NO: 11</entry><entry namest="col4" nameend="col4" align="center">39</entry><entry namest="col5" nameend="col5" align="center">55</entry></row><row><entry namest="col1" nameend="col1" align="left">AtMVR3-5</entry><entry namest="col2" nameend="col2" align="left">SEQ ID NO:12</entry><entry namest="col3" nameend="col3" align="left">SEQ ID NO:13</entry><entry namest="col4" nameend="col4" align="center">37</entry><entry namest="col5" nameend="col5" align="center">54</entry></row><row><entry namest="col1" nameend="col1" align="left">AtMVR3-6</entry><entry namest="col2" nameend="col2" align="left">SEQ ID NO: 14</entry><entry namest="col3" nameend="col3" align="left">SEQ ID NO: 15</entry><entry namest="col4" nameend="col4" align="center">36</entry><entry namest="col5" nameend="col5" align="center">52</entry></row><row><entry namest="col1" nameend="col1" align="left">AtMVR3-7</entry><entry namest="col2" nameend="col2" align="left">SEQ ID NO: 16</entry><entry namest="col3" nameend="col3" align="left">SEQ ID NO: 17</entry><entry namest="col4" nameend="col4" align="center">34</entry><entry namest="col5" nameend="col5" align="center">52</entry></row><row><entry namest="col1" nameend="col1" align="left">AtMVR3-8</entry><entry namest="col2" nameend="col2" align="left">SEQ ID NO: 18</entry><entry namest="col3" nameend="col3" align="left">SEQ ID NO: 19</entry><entry namest="col4" nameend="col4" align="center">34</entry><entry namest="col5" nameend="col5" align="center">51</entry></row><row><entry namest="col1" nameend="col1" align="left">AtMVR3-9</entry><entry namest="col2" nameend="col2" align="left">SEQ ID NO: 20</entry><entry namest="col3" nameend="col3" align="left">SEQ ID NO: 21</entry><entry namest="col4" nameend="col4" align="center">37</entry><entry namest="col5" nameend="col5" align="center">58</entry></row><row><entry namest="col1" nameend="col1" align="left">AtMVR3-10</entry><entry namest="col2" nameend="col2" align="left">SEQ ID NO: 22</entry><entry namest="col3" nameend="col3" align="left">SEQ ID NO: 23</entry><entry namest="col4" nameend="col4" align="center">25</entry><entry namest="col5" nameend="col5" align="center">44</entry></row><row><entry namest="col1" nameend="col1" align="left">AtMVR3-11</entry><entry namest="col2" nameend="col2" align="left">SEQ ID NO: 24</entry><entry namest="col3" nameend="col3" align="left">SEQ ID NO: 25</entry><entry namest="col4" nameend="col4" align="center">33*</entry><entry namest="col5" nameend="col5" align="center">51*</entry></row><row><entry namest="col1" nameend="col1" align="left">AtMVR3-12</entry><entry namest="col2" nameend="col2" align="left">SEQ ID NO: 26</entry><entry namest="col3" nameend="col3" align="left">SEQ ID NO: 27</entry><entry namest="col4" nameend="col4" align="center">25</entry><entry namest="col5" nameend="col5" align="center">41</entry></row><row rowsep="1"><entry namest="col1" nameend="col1" align="left">AtMVR3-13</entry><entry namest="col2" nameend="col2" align="left">SEQ ID NO: 28</entry><entry namest="col3" nameend="col3" align="left">SEQ ID NO: 29</entry><entry namest="col4" nameend="col4" align="center">22</entry><entry namest="col5" nameend="col5" align="center">41</entry></row></tbody></tgroup><tgroup cols="5" colsep="0" rowsep="0"><colspec colnum="1" colname="col1" colwidth="31.50mm" /><colspec colnum="2" colname="col2" colwidth="31.50mm" /><colspec colnum="3" colname="col3" colwidth="31.50mm" /><colspec colnum="4" colname="col4" colwidth="31.50mm" /><colspec colnum="5" colname="col5" colwidth="31.50mm" /><tbody valign="top"><row><entry namest="col1" nameend="col5" align="justify">* The comparison with AtMVR3-11 shows the result of homology comparison with a partial sequence of AtMVR3-11.</entry></row></tbody></tgroup></table></tables>

0097As shown in Table 9, homology between AtMVR and the 13 AtMVR homologous genes ranged from 22 to 57% for Identities and from 41 to 70% for Positives.

[Example 3] Construction of AtMVR expression vector for plant and production of AtMVR transgenic plant

0098The transformation techniques applied herein were in accordance with a vector system described by Pellegrineschi et al. (Biochemical Society Transitions 23, 247-250, 1995) based on the Agrobacterium gene transport system outlined by Hinchee et al. (Plant Cell and Tissue Culture, pp. 231-270, Eds. I. K. Vasil, T. A Thorpe, Kluwer Academic Publisher, 1994).

(1) Construction of AtMVR expression vector for plant

0099The AtMVR gene sequence was excised from pAtMVR using SacI/SacII and subcloned into pBlueScript (STRATAGENE). Subsequently, a fragment containing the AtMVR gene sequence was cleaved with XbaI/SacI and introduced at XbaI/SacI site that is present downstream of the CaMV 35S promoter of pBI121 (manufactured by Clontech). The resulting vector was used below as an AtMVR expression vector for plant.

(2) Production of ATMVR transgenic plant

0100The AtMVR expression vector for plant produced in the above (1) was introduced into <i>Agrobacterium tumefaciens</i> LBA4404 strain by the electroporation method (Plant Molecular Biology Manual, Second Edition, B. G. Stanton, A. S. Robbert, Kluwer Academic Publishers, 1994). Subsequently, the <i>Agrobacterium tumefaciens</i> having the AtMVR expression vector for plant introduced therein was introduced into wild-type <i>Arabidopsis thaliana</i> ecotype Col-0 by an infiltration method described by Clough et al. (The Plant Journal 16: 735-743, 1998).

0101Transformants were screened in a kanamycin-containing medium, and a T3 generation plant (homozygous line having 1 AtMVR gene introduced) was produced by self-pollination.

0102Next, the amount of the introduced AtMVR gene expressed was examined. Seeds of a transformant produced as described above and a non-transformant were respectively planted in pots containing vermiculite (Asahi Kagaku Kogyo Co., Ltd.) and allowed to grow for approximately one month under a light intensity of 100 µE/m²/s at 23°C with a photoperiod condition of 16 hrs photoperiod/8 hrs dark period.

0103After growing, total RNA was extracted from the transformant and the wild-type <i>Arabidopsis thaliana</i> ecotype Col-0 non-transformant using the RNeasy Plant Mini Kit (QIAGEN). Thereafter, 1 µg of RNA was subjected to reverse transcription using the ProSTAR First Strand RT-PCR Kit (STRATAGEN). PCR was then performed using the following reaction mixture (Table 10) containing Takara EX-Taq (TAKARA BIO) employing 1/50 volume of the synthesized cDNA as a template and using primers for the AtMVR gene (primer 141d1 (SEQ ID NO: 38) and primer 141d2 (SEQ ID NO: 39)). <tables id="tabl0010" num="0010"><table frame="all"><title>[Table 10]</title><tgroup cols="2" colsep="1" rowsep="0"><colspec colnum="1" colname="col1" colwidth="78.75mm" /><colspec colnum="2" colname="col2" colwidth="78.75mm" /><tbody valign="top"><row><entry namest="col1" nameend="col1" align="left">PCR reaction mixture</entry><entry namest="col2" nameend="col2" /></row><row><entry namest="col1" nameend="col1" align="left">Template (cDNA)</entry><entry namest="col2" nameend="col2" align="left">50 ng</entry></row><row><entry namest="col1" nameend="col1" align="left">10x Ex Taq buffer (TAKARA BIO Inc.)</entry><entry namest="col2" nameend="col2" align="left">2 µl</entry></row><row><entry namest="col1" nameend="col1" align="left">dNTPs</entry><entry namest="col2" nameend="col2" align="left">200 µM</entry></row><row><entry namest="col1" nameend="col1" align="left">Each primer</entry><entry namest="col2" nameend="col2" align="left">0.2 µM</entry></row><row rowsep="1"><entry namest="col1" nameend="col1" align="left">Takara EX-Taq</entry><entry namest="col2" nameend="col2" align="left">1 unit</entry></row><row rowsep="1"><entry namest="col1" nameend="col1" align="left">Total volume</entry><entry namest="col2" nameend="col2" align="left">20 µl</entry></row></tbody></tgroup></table></tables>

0104Thirty cycles of 94°C (30 sec)/55°C (30 sec)/72°C (60 sec) were employed as the reaction conditions.

0105The amplification products were subjected to electrophoresis on agarose gel. FIG. 1 shows the results of electrophoresis. As can be seen from FIG. 1, in comparison to the non-transformant, the produced transformant overexpressed the AtMVR gene.

[Example 4] Evaluation of paraquat resistance of AtMVR gene transformant

0106Seeds derived from the produced AtMVR gene transformant and non-transformant (wild-type <i>Arabidopsis thaliana</i> ecotype Col-0) were sterilely inoculated in 1/2 MS agar (1%) medium (2.3 g/l of Murashige and Skoog Plant Salt Mixture (Wako Pure Chemical Industries Ltd.), 1.5 mg/l of thiamine hydrochloride, 2.5 mg/l of nicotinic acid, 0.25 mg/l of pyridoxine hydrochloride, 1.5% of sucrose) containing 3 µM of paraquat (methyl viologen (Sigma Chemical Co.)), and cultured for eight days at 22°C under irradiation of light of 60 µmol/m²/s (cycle of 16 hrs photoperiod/8 hrs dark period). After culture, the growth of germinated individuals was evaluated. The results are shown in FIG. 2, wherein FIG. 2B is a photograph showing growth of an AtMVR gene transformant and a non-transformant in a 1/2 MS culture medium without paraquat, and FIG. 2C is a photograph showing growth of an AtMVR gene transformant and a non-transformant in a 1/2 MS culture medium with paraquat. FIG. 2A is a schematic diagram showing the location of the AtMVR gene transformant and the non-transformant in FIGS. 2B and 2C.

0107As can be seen from FIG. 2B, the results showed that in the culture medium without paraquat, the AtMVR gene transformant exhibited the same growth as the non-transformant. Meanwhile, as can be seen from FIG. 2C, in a medium containing paraquat the non-transformant developed chlorosis and died, i.e. growth was remarkably inhibited, while in contrast the seedling of the AtMVR gene transformant was able to grow. Thus, it was confirmed that in a medium without paraquat, the AtMVR gene transformant exhibited the same growth as a non-transformant regardless of expression of the AtMVR gene, and also that in a medium with paraquat, the AtMVR gene transformant had clearly greater paraquat resistance than the non-transformant.

[Example 5] Isolation of vascular tissue/trichome-specific promoter

0108Seeds of <i>Arabidopsis thaliana</i> (<i>Arabidopsis thaliana</i> ecotype Columbia (Col-0)) were planted in pots containing vermiculite (Asahi Kagaku Kogyo Co., Ltd.) and allowed to grow for approximately one month under a light intensity of 100 µE/m²/s at 23°C, under a photoperiod condition of 16 hrs photoperiod/8 hrs dark period.

0109After growing, genome DNA was prepared from leaves of individuals using DNeasy Plant Mini Kit (QIAGEN). Next, PCR was performed using the following reaction mixture (Table 11) containing Takara EX-Taq (TAKARA BIO Inc.) employing the obtained genome DNA as a template and using a primer 141dpF (SEQ ID NO: 40) and a primer 141dpR (SEQ ID NO: 41) based on the AtMVR gene fragment (SEQ ID NO: 35) described in above Example 1 under the reaction conditions described below. <tables id="tabl0011" num="0011"><table frame="all"><title>[Table 11]</title><tgroup cols="2" colsep="1" rowsep="0"><colspec colnum="1" colname="col1" colwidth="78.75mm" /><colspec colnum="2" colname="col2" colwidth="78.75mm" /><tbody valign="top"><row><entry namest="col1" nameend="col1" align="left">Template genome DNA</entry><entry namest="col2" nameend="col2" align="left">50 ng</entry></row><row><entry namest="col1" nameend="col1" align="left">10x Ex Taq buffer (TAKARA BIO Inc.)</entry><entry namest="col2" nameend="col2" align="left">2 µl</entry></row><row><entry namest="col1" nameend="col1" align="left">dNTPs</entry><entry namest="col2" nameend="col2" align="left">200 µM</entry></row><row><entry namest="col1" nameend="col1" align="left">Each primer</entry><entry namest="col2" nameend="col2" align="left">0.2 µM</entry></row><row rowsep="1"><entry namest="col1" nameend="col1" align="left">Takara EX-Taq</entry><entry namest="col2" nameend="col2" align="left">1 unit</entry></row><row rowsep="1"><entry namest="col1" nameend="col1" align="left">Total volume</entry><entry namest="col2" nameend="col2" align="left">20 µl</entry></row></tbody></tgroup></table></tables>

0110The reaction conditions were thirty cycles of 94°C (30 sec)/55°C (30 sec)/72°C (60 sec).

0111The amplification product was cloned into pGEM-T Easy vector (Promega Corp.) and the nucleotide sequence was then determined using the ABI PRISM 310 genetic analyzer (Applied Biosystems). As a result, an AtMVR promoter of 1722 bp (SEQ ID NO: 3) was obtained.

[Example 6] Analysis of tissue specificity of vascular tissue/trichome-specific promoter

(1) Construction of expression vector having AtMVR promoter

0112The AtMVR promoter was excised from the pGEM-T Easy vector having the AtMVR promoter (SEQ ID NO: 3) produced in Example 5 using HindIII/PstI and then subcloned into the upstream region of CaMV 35S promoter of pBI221 (Clontech). The resulting vector was treated with PstI/SmaI to remove the CaMV 35S promoter, and the ends were blunted using DNA T4 polymerase (TAKARA BIO Inc.) and allowed to self-ligate. As a result, the AtMVR promoter was ligated into the vector upstream of the β-Glucuronidase (GUS) gene. Subsequently, a fragment containing the AtMVR promoter and the GUS gene was excised from the above vector using HindIII/EcoRI, and then substituted for CaMV 35S promoter-β-GUS gene of pBI121 (Clontech). The vector thus obtained was employed as an expression vector having the AtMVR promoter for use below.

(2) Production of transgenic plant

0113In a similar manner to Example 3(2), the above expression vector having the AtMVR promoter was introduced into <i>Agrobacterium tumefaciens</i> LBA4404 strain, and this was then introduced into wild-type <i>Arabidopsis thaliana</i> ecotype Col-0 by the infiltration method. Thereafter, transformants were screened in a kanamycin-containing medium, and a T3 generation plant was produced by self-pollination.

(3) Analysis of tissue specificity of AtMVR promoter

0114Seeds derived from the transformant produced in the above (2) were sterilely inoculated in 1/2 MS agar (1%) medium (2.3 g/l of Murashige and Skoog Plant Salt Mixture (Wako Pure Chemical Industries Ltd.), 1.5 mg/l of thiamine hydrochloride, 2.5 mg/l of nicotinic acid, 0.25 mg/l of pyridoxine hydrochloride, 1.5% of sucrose), and cultured at 22°C under irradiation of light of 60 µE/m²/s (cycle of 16 hrs photoperiod/8 hrs dark period) for approximately 7 days.

0115After culture, transformants that grew were fixed with acetone. A reaction mixture containing 5-brome-4-chloro-3-indolyl-β-D-glucuronide (X-Gluc) was added to the fixed tissue so as to immerse the entire tissue. The composition of the reaction mixture was: 1.9 mM of X-Gluc, 0.5 mM of K₃Fe(CN)₆, 0.5 mM of K₄Fe(CN)₆, and 0.3% of Triton X-100.

0116The container was then sealed and incubated overnight in a 37°C incubator. Thereafter, 70% ethanol was added to the mixture to terminate the reaction, and coloring was observed. (Shokubutsu No Saibo Wo Miru Jikken Purotokoru (Protocols of Experiments for Observing Cells of Plants), Eds. Fukuda H., Nishimura M., &amp; Nakamura K., (1997), pp 71-79, Shujunsha Co., Ltd., Tokyo). The results are shown in FIGS. 3 to 5, wherein FIGS. 3 to 5 are photomicrographs of an entire transformant, a leaf of a transformant, and a root of a transformant, respectively.

0117As can be seen from FIGS. 3 to 5, specific coloring was observed in the vascular tissue and trichome. Thus, it was confirmed that the obtained AtMVR promoter (SEQ ID NO: 3) is a transcriptional promoter having tissue-specific transcriptional activity in a vascular tissue and trichome.

Free Text for Sequence Listing

0118SEQ ID NOS: 31 to 41 are primers.

0119In SEQ ID NO: 34, n represents a, g, c, or t (location: 1 and 11), s represents g or c (location: 7), and w represents a or t (location: 8 and 13).

0120In SEQ ID NO: 35, n represents a, g, c, or t (location: 13, 35, 73, 108, 156, 190, 198 and 201):

Industrial Applicability

0121According to the present invention there is provided a paraquat resistance gene and a vascular tissue- and trichome-specific promoter. A paraquat resistance gene according to the present invention is capable of imparting resistance that is specific to paraquat without affecting growth regulation that undergoes control by the generation of active oxygens under various environments.

0122Further, the vascular tissue- and trichome-specific promoter according to the present invention enables the regulation of gene expression in a vascular tissue and trichome of a plant.

0123A paraquat resistance gene and a vascular tissue- and trichome-specific promoter are provided. The paraquat resistance gene and the vascular tissue- and trichome-specific promoter are isolated by identifying and analyzing genes of <i>Arabidopsis thaliana.</i><img file="EP1514941A2_D0001.tif" /><img file="EP1514941A2_D0002.tif" /><img file="EP1514941A2_D0003.tif" /><img file="EP1514941A2_D0004.tif" /><img file="EP1514941A2_D0005.tif" /><img file="EP1514941A2_D0006.tif" /><img file="EP1514941A2_D0007.tif" /><img file="EP1514941A2_D0008.tif" /><img file="EP1514941A2_D0009.tif" /><img file="EP1514941A2_D0010.tif" /><img file="EP1514941A2_D0011.tif" /><img file="EP1514941A2_D0012.tif" /><img file="EP1514941A2_D0013.tif" /><img file="EP1514941A2_D0014.tif" /><img file="EP1514941A2_D0015.tif" /><img file="EP1514941A2_D0016.tif" /><img file="EP1514941A2_D0017.tif" /><img file="EP1514941A2_D0018.tif" /><img file="EP1514941A2_D0019.tif" /><img file="EP1514941A2_D0020.tif" /><img file="EP1514941A2_D0021.tif" /><img file="EP1514941A2_D0022.tif" /><img file="EP1514941A2_D0023.tif" /><img file="EP1514941A2_D0024.tif" /><img file="EP1514941A2_D0025.tif" /><img file="EP1514941A2_D0026.tif" /><img file="EP1514941A2_D0027.tif" /><img file="EP1514941A2_D0028.tif" /><img file="EP1514941A2_D0029.tif" /><img file="EP1514941A2_D0030.tif" /><img file="EP1514941A2_D0031.tif" /><img file="EP1514941A2_D0032.tif" /><img file="EP1514941A2_D0033.tif" /><img file="EP1514941A2_D0034.tif" /><img file="EP1514941A2_D0035.tif" /><img file="EP1514941A2_D0036.tif" /><img file="EP1514941A2_D0037.tif" /><img file="EP1514941A2_D0038.tif" /><img file="EP1514941A2_D0039.tif" /><img file="EP1514941A2_D0040.tif" /><img file="EP1514941A2_D0041.tif" /><img file="EP1514941A2_D0042.tif" /><img file="EP1514941A2_D0043.tif" /><img file="EP1514941A2_D0044.tif" /><img file="EP1514941A2_D0045.tif" />